Author(s):
Andika Purnama Gymnastiar, Dini Sri Damayanti, Andri Tilaqza
Email(s):
dinisridamayanti@unisma.ac.id
DOI:
10.52711/0974-360X.2024.00896 
Address:
Andika Purnama Gymnastiar1, Dini Sri Damayanti1*, Andri Tilaqza2
1Department of Physiology, Faculty of Medicine, University of Islam Malang (UNISMA), Malang 65145 East Java, Indonesia.
2Department of Pharmacy, Faculty of Medicine, University of Islam Malang (UNISMA), Malang 65145 East Java, Indonesia.
*Corresponding Author
Published In:
Volume - 17,
Issue - 12,
Year - 2024
ABSTRACT:
Angiotensin Converting Enzyme (ACE) inhibitor and Angiotensin II Reseptor Blocker (ARB) are a treatment mechanism for patients with hypertension. Papaya leaves have been proven to have the potential to lower blood pressure in hypertensive rat models through the mechanism of ACE inhibition. However, this study has not yet identified the active compounds that act as antihypertensive agents or predicted their safety. This study aims to predict the mechanisms of action of the active compounds in papaya leaves as antihypertensive agents through ACE and Angiotensin II Receptor Type 1 (AT1R) inhibition in silico, and to determine the potential for their development as oral drugs and their safety. The study uses computational design with 3D structures of the target proteins ACE and AT1R downloaded from the Protein Data Bank (PDB). The ligands, which are active compounds from Carica papaya leaves, were obtained from literature, and their 3D structures were downloaded from PubChem. The docking process was carried out using AutoDock Tools. Physicochemical predictions and pharmacokinetics predictions were conducted using the SwissADME and pkCSM websites.The indicators used for the affinity of active compounds are free energy and structural similarity of ligands compared to the drugs control. Solubility and pharmacokinetics follow the 5 criteria of Lipinski's rule, and the values for absorption, distribution, metabolism, and excretion, as well as hepatotoxicity or IC50. The docking results on the ACE protein indicate that the active compounds rutin, luteolin, epicatechin, and caffeic acid have free binding energy values below ?G -7 kcal/mol. Meanwhile, on the AT1R protein, the active compounds carpaine and rutin show free binding energy values closest to ?G -7 kcal/mol. Caffeic acid, Carpaine, Epicatechin, and Luteolin have good solubility and meet the 5 criteria of Lipinski's rule.The active compound carpaine has potential on both ACE and AT1R target proteins but exhibits weaker affinity compared to the control drug.
Cite this article:
Andika Purnama Gymnastiar, Dini Sri Damayanti, Andri Tilaqza. Molecular Docking of Carica papaya leaves as Antihypertensive at ACE and Angiotensin II Receptor. Research Journal Pharmacy and Technology. 2024;17(12):5908-4. doi: 10.52711/0974-360X.2024.00896
Cite(Electronic):
Andika Purnama Gymnastiar, Dini Sri Damayanti, Andri Tilaqza. Molecular Docking of Carica papaya leaves as Antihypertensive at ACE and Angiotensin II Receptor. Research Journal Pharmacy and Technology. 2024;17(12):5908-4. doi: 10.52711/0974-360X.2024.00896 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-12-33
REFERENCES:
1. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Biochemistry. 1988; 85(24): 9386–90. https://doi.org/10.1073/pnas.85.24.9386
2. Eguchi S, Kawai T, Scalia R, Rizzo V. Understanding Angiotensin II type 1 receptor signaling in vascular pathophysiology. Hypertension. 2018; May 1; 71(5): 804–10. https://doi.org/10.1161/HYPERTENSIONAHA.118.10266
3. Shrout T, Rudy DW, Piascik MT. Hypertension update JNC8 and beyond. Curr Opin Pharmacol. 2017; Apr 1; 33: 41–6. https://doi.org/10.1016/j.coph.2017.03.004
4. Aravind G, Debjit B, Duraivel S, Harish G. Traditional and medicinal uses of Carica papaya. Journal of Medicinal Plants Studies. 2013; 1(1): 7–15. www.plantsjournal.com
5. Santana LF, Inada AC, Santo BLS do E, Filiú WFO, Pott A, Alves FM, et al. Nutraceutical potential of carica papaya in metabolic syndrome. Nutrients. 2019; Jul 1; 11(7): 1–19. https://doi.org/10.3390/nu11071608
6. Brasil GA lexandre, Ronchi SN ascimento, do Nascimento AM arques, de Lima EM iranda, Romão W, da Costa HB arcellos, et al. Antihypertensive effect of Carica papaya via a reduction in ACE activity and improved baroreflex. Planta Med. 2014; Nov 1; 80(17): 1580–7. https://doi.org/10.1055/s-0034-1383122
7. Filimonov DA, Lagunin AA, Gloriozova TA, Rudik A V, Druzhilovskii DS, Pogodin P V, et al. Prediction Of The Biological Activity Spectra Of Organic Compounds Using The Pass Online Web Resource. Chem Heterocycl Compd (N Y). 2014; 50(3): 444–57. https://doi.org/10.1007/s10593-014-1496-1
8. Tilaqza A, Herbani M. Studi In Silico Potensi Anti Hipertensi dan Prediksi Profil Farmakokinetika Daun Jati Belanda (Guazuma ulmifolia. Lamk). Jurnal Kesehatan Islam [Internet]. 2021; 10(2): 45–52. https://doi.org/10.33474/jki.v10i2.13821
9. Shivanika C, Deepak Kumar S, Ragunathan V, Tiwari P, Sumitha A, Brindha Devi P. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. J Biomol Struct Dyn. 2022; 40(2): 585–611. https://doi.org/10.1080/07391102.2020.1815584
10. Ramírez D, Caballero J. Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? Molecules. 2018; 23(5): 1–17. https://doi.org/10.3390/molecules23051038
11. Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; Mar 3; 7(42717): 1–13. https://doi.org/10.1038/srep42717
12. Pires DEV, Kaminskas LM, Ascher DB. Prediction and optimization of pharmacokinetic and toxicity properties of the ligand. Methods in Molecular Biology. 2018; 1762: 271–84. https://doi.org/10.1007/978-1-4939-7756-7_14
13. Bazyar H, Zare Javid A, Ahangarpour A, Zaman F, Hosseini SA, Zohoori V, et al. The effects of rutin supplement on blood pressure markers, some serum antioxidant enzymes, and quality of life in patients with type 2 diabetes mellitus compared with placebo. Front Nutr. 2023; 10: 1–12. https://doi.org/10.3389/fnut.2023.1214420
14. Damayanti DS, Iktiarani A. Chorogenic Acid, Dehydrocarpaine I and D1 Alpha Tocopherol from Papaya Leaves (Papaya Carica) as an Anti-Inflammatory Candidate That Inhibits TNF Alpha Receptors. 7th ed. Turkey: International Students Science Congress; 2023. 333–341 p. https://doi.org/10.52460/issc.2023.049
15. Su J, Xu HT, Yu JJ, Gao JL, Lei J, Yin QS, et al. Luteolin Ameliorates Hypertensive Vascular Remodeling through Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells. Evidence-based Complementary and Alternative Medicine. 2015; 1–14. https://doi.org/10.1155/2015/364876
16. Kadar NNMA, Ahmad F, Teoh SL, Yahaya MF. Caffeic Acid on Metabolic Syndrome: A Review. Molecules. 2021; Sep 9; 26(18): 1–14. https://doi.org/10.3390/molecules26185490
17. Goretta LA, Ottaviani JI, Keen CL, Fraga CG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett. 2003; Dec 18; 555(3): 597–600. https://doi.org/10.1016/S0014-5793(03)01355-3
18. Bernatova I, Liskova S. Mechanisms modified by epicatechin and taxifolin relevant for the treatment of hypertension and viral infection: Knowledge from preclinical studies. Antioxidants. 2021; Mar 1; 10(3): 1–26. https://doi.org/10.3390/antiox10030467
19. Benet LZ, Hosey CM, Ursu O, Oprea TI. BDDCS the Rule of 5 and drugability. Adv Drug Deliv Rev. 2016; Jun 1; 101: 89–98. https://doi.org/10.1016/j.addr.2016.05.007
20. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012; Dec; 64: 4–17. https://doi.org/10.1016/j.addr.2012.09.019
21. Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015; May 14; 58(9): 4066–72. https://doi.org/10.1021/acs.jmedchem.5b00104
22. Yeni Y, Rachmania RA. The Prediction of Pharmacokinetic Properties of Compounds in Hemigraphis alternata (Burm.F.) T. Ander Leaves Using pkCSM. Indonesian Journal of Chemistry. 2022; 22(4): 1081–9. https://doi.org/10.22146/ijc.73117
23. Krihariyani D, Sasongkowati R, Haryanto E. Studi In Silico Sifat Farmakokinetik, Toksisitas, Dan Aktivitas Imunomodulator Brazilein Kayu Secang Terhadap Enzim 3-Chymotrypsin-Like Cysteine Protease Coronavirus. Journal of Indonesian Medical Laboratory and Science. 2020; 1(1): 76–90. https://doi.org/10.53699/joimedlabs.v1i1.14
24. Sevrioukova IF, Poulos TL. Understanding the mechanism of cytochrome P450 3A4: Recent advances and remaining problems. Dalton Transactions. 2013; Mar 7; 42(9): 3116–26. https://doi.org/10.1039/c2dt31833d
25. Paniagua AC, Amariles P. Hepatotoxicity by Drugs. In: Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. InTech; 2018. p. 76–92. https://doi.org/10.5772/intechopen.72005
26. Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023; Dec 1; 13(1): 1–18. https://doi.org/10.1038/s41598-023-40160-2
27. Vidal-Limon A, Aguilar-Toalá JE, Liceaga AM. Integration of Molecular Docking Analysis and Molecular Dynamics Simulations for Studying Food Proteins and Bioactive Peptides. J Agric Food Chem. 2022; Feb 2; 70(4): 934–43. https://doi.org/10.1021/acs.jafc.1c06110